logo

Spring Bank Pharmaceuticals, Inc. (SBPH)



Trade SBPH now with
  Date
  Headline
8/8/2018 9:49:39 PM Spring Bank Pharma Announces Pricing Of Underwritten Public Offering Of 3 Mln Shares At $12.50/shr
4/27/2018 8:13:46 AM Spring Bank Pharma Q1 Net Loss $4.9 Mln Or $0.37/Shr Vs $6.5 Mln Or $0.69/Shr Last Year
4/10/2018 8:34:37 AM Spring Bank Announces Expanded Inarigivir Data From ACHIEVE Trial To Be Presented At EASL
3/5/2018 4:04:05 PM Spring Bank Pharmaceuticals Appoints Timothy Clackson To Its Board Of Directors
11/6/2017 9:17:58 AM B. Riley FBR Initiates Spring Bank Pharmaceuticals, Inc. (SBPH) At Buy With $30 Price Target
10/31/2017 6:55:13 AM Spring Bank Pharma Q3 Loss Widens To $10.8 Mln Or $0.85/shr From $4.1 Mln Or $0.53/shr Last Year
7/10/2017 8:36:03 AM Spring Bank Collaborates With Gilead For Hepatitis B Phase 2 Study Exploring Treatment Of SB 9200 And Vemlidy
6/22/2017 9:06:56 AM Spring Bank Pharmaceuticals Prices Public Offering Of 2.88 Mln Shares At $13/Shr
6/21/2017 4:04:34 PM Spring Bank Pharma Announces Proposed Public Offering Of Common Stock
6/7/2017 7:08:46 AM Spring Bank Announces Publication Of An Abstract At ASCO Related To Its Lead STING Agonist Candidate, SB 11285
4/28/2017 8:37:11 AM Spring Bank Pharma Q1 Net Loss $6.5 Mln Or $0.69/shr Vs. Net Loss $6.5 Mln Or $1.11/shr Last Year